Nautilus Biotechnology (NAUT) Retained Earnings (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Retained Earnings data on file, last reported at -$346.7 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 19.72% year-over-year to -$346.7 million; the trailing twelve-month figure through Mar 2026 stood at -$346.7 million (down 19.72% YoY), and the FY2025 full-year result was $243000.0, up 326.32% from the prior year.
• Retained Earnings fell to -$346.7 million in Q1 2026, from $243000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $485.7 million in Q2 2025 to a low of -$346.7 million in Q1 2026.
• A 5-year average of -$87.9 million and a median of -$169.3 million in 2023 frame the typical range for Retained Earnings.
• Peak annual rise in Retained Earnings reached 575.3% in 2023, while the deepest fall reached 10808.25% in 2023.
• Tracing NAUT's Retained Earnings over 5 years: stood at -$1.9 million in 2022, then tumbled by 10808.25% to -$202.2 million in 2023, then jumped by 100.03% to $57000.0 in 2024, then surged by 326.32% to $243000.0 in 2025, then plunged by 142774.9% to -$346.7 million in 2026.
• Business Quant data shows NAUT's Retained Earnings at -$346.7 million in Q1 2026, $243000.0 in Q4 2025, and -$318.2 million in Q3 2025.